Nvidias Annual Spending on Taiwan AI Suppliers Could Reach 150 Billion Says Jensen Huang BP plc Examined as a Natural Gas Stock for Transitional Power Investments Robinhood Integrates AI Agents for Automated Trading and Credit Card Payments Fed Minutes Reveal Potential Rate Hikes If Iran War Sustains Inflation Pressures Jobless Claims Hold at Low Levels Signaling Tight Labor Market Dollar Declines on Growing Prospects of USIran Agreement Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges SLM Q1 2026 Earnings EPS Surges Past Estimates by 356 Stock Slips BGS Q1 2026 Earnings Earnings Beat Estimates by 457 as Bottom Line Exceeds Expectations MPT Q1 2026 Earnings EPS Surges Past Estimates with 65 Surprise NOK Q1 2026 Earnings EPS Surprises to the Upside as Stock Declines Acco Brands ACCO Rallies 119 to 382 Support and Resistance in Focus Medicus Pharma MDCX Rallies 49 as Shares Test Resistance Near 032 Centrus Energy LEU Holds Steady Above Support After Modest Gain Holley Inc HLLY Shows Modest Upside as Shares Test Key Resistance Near 264 TTEK Q1 2026 Earnings EPS Beats Estimates by 417 Stock Rises Slightly ROP Q1 2026 Earnings Earnings Beat Driven by Strong Execution in Software and Industrial Portfolios VLN Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Uncertainties RCUS Q1 2026 Earnings WiderThanExpected Loss as Pipeline Spending Rises Guardian Pharmacy Services Q1 2026 Earnings EPS Miss Drags but Stock Holds Steady OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline Micron Technologys Potential Upside Draws Bullish Analyst Call SBGI Q1 2026 Earnings A Stunning Profit Surprise in a Challenging Broadcast Landscape Franklin Financial Services FRAF Gains Ground Testing Key Levels After 225 Rally Axe Compute Inc AGPU Retreats 361 as Selling Pressure Tests Key Support Citizens Inc CIA Holds Steady at 494 as Support Levels Are Tested Sequans Communications SQNS Slides 55 as Selling Pressure Mounts Key Levels in Focus WESCO International WCC Edges Higher as Momentum Builds Above Key Support KTN Holds Near 2607 Amid Modest Decline Support at 2477 Remains Key Autolus Therapeutics AUTL Edges Higher Testing Resistance Near 181